Horan Securities’s Endologix Inc ELGX Stock Holding History

Horan Securities’s Portfolio ELGX Stock Details ELGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-7	Closed	–	–	213
2017 Q3	$0	Buy	+7	New	+$319	﹤0.01%	199

Other funds holding ELGX

ACH

ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CWAM

Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Horan Securities's ELGX Position: Q4 2017 in Review

Horan Securities sold out of Endologix Inc (ELGX) in Q4 2017, closing a stake of 7 shares.

Horan Securities first reported a position in ELGX in Q3 2017 and held it in 1 quarter. The position peaked at $0 in Q3 2017. 103 funds tracked by Wall St. Rank hold ELGX as of Q4 2017.

Horan Securities reported no remaining Endologix Inc position as of Q4 2017 after selling out during the quarter.
Horan Securities sold 7 Endologix Inc shares in Q4 2017.
Horan Securities first reported a position in Endologix Inc in Q3 2017 and held it in 1 quarter.
Horan Securities's Endologix Inc position peaked at $0 in Q3 2017.
103 funds tracked by Wall St. Rank held Endologix Inc as of Q4 2017.

Based on Horan Securities's 13F filing for Q4 2017, filed 16 Jan 2018.